Clinical Trials Logo

Clinical Trial Summary

Sexual abuse committed on children is a major public health problem because of its frequency and its severe consequences on the mental health of victims.

Objective: to compare the therapeutic efficacy of cyproterone acetate (CPA) and leuprolide, with the hypothesis that leuprolide will be more effective.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00601276
Study type Interventional
Source Institut National de la Santé Et de la Recherche Médicale, France
Contact
Status Terminated
Phase Phase 3
Start date December 2007
Completion date June 2009

See also
  Status Clinical Trial Phase
Recruiting NCT06133569 - ReDirection - Self Help Program for Minor Attracted Individuals N/A
Recruiting NCT06133595 - Mi Bridge - Motivational Interviewing to Facilitate Help-seeking Among Minor Attracted Individuals N/A
Active, not recruiting NCT00220350 - Lupron Sex Offender Therapy Phase 2/Phase 3
Recruiting NCT05663047 - Prevent It 2.0/GPP -iCBT to Reduce the Risk of Committing Child Sexual Abuse N/A
Completed NCT02822664 - Analysis of Cerebral Correlates of Pedophilia With Neuroimaging Techniques N/A
Recruiting NCT03825627 - From Attention to Behavior: Increasing Behavioral Inhibition N/A
Recruiting NCT05831657 - Prevent It 2.0/PRIORITY - An iCBT to Reduce the Risk of Committing Child Sexual Abuse N/A
Recruiting NCT01541150 - Impaired Decision Making in Pedophilic Offenders Phase 4